Characterization of cytokines present in middle ear effusions. 1991

R F Yellon, and G Leonard, and P T Marucha, and R Craven, and R J Carpenter, and W B Lehmann, and J A Burleson, and D L Kreutzer
University of Connecticut Health Center Division of Otolaryngology, Farmington 06032.

Retention of inflammatory mediators and cells in the middle ear cleft during chronic otitis media with effusion (COME), results in ongoing inflammation with the potential for pathologic changes and hearing loss. Cytokines are glycoproteins produced by macrophages and other cells. Activities of cytokines include fever production, osteoclast, fibroblast, phagocyte and cytotoxic cell activation, regulation of antibody formation, and inhibition of cartilage, bone and endothelial cell growth. Using enzyme-linked immunospecific assays we measured levels of six cytokines in middle ear effusions (MEE) from children with COME. Significant levels of four cytokines: interleukin-1-beta (greater than 50 pg/ml), interleukin-2 (greater than 300 pg/ml), tumor necrosis factor-alpha (greater than 40 pg/ml), and gamma-interferon (greater than 6.25 pg/ml) were found in 51%, 54%, 63%, and 19% of MEE, respectively. In contrast, levels of a fifth cytokine, granulocyte-macrophage colony-stimulating factor, and a sixth cytokine, interleukin-4, were undetectable. Age was observed to have a significant effect on the levels of specific cytokines. Interleukin-1 (IL-1) correlated inversely (P less than .02) with age such that the younger the child, the higher the level of IL-1 in MEE. Tumor necrosis factor-alpha (TNF) correlated directly (P less than .005) with age such that the older the child, the higher the level of TNF in MEE. Children undergoing tympanostomy on multiple occasions had average MEE TNF levels (234.2 +/- 109.1 pg/mg total protein) that were nearly 14 times higher (P less than .005) than those from children undergoing their first tympanostomy (16.9 +/- 3.0 pg/mg total protein). Thus IL-1 correlated with the early stages of COME, while TNF correlated with persistence of disease. The presence of these cytokines in MEE may be responsible for the mucosal damage, bone erosion, fibrosis, and resulting hearing loss seen in some cases of COME.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008297 Male Males
D010034 Otitis Media with Effusion Inflammation of the middle ear with a clear pale yellow-colored transudate. Middle Ear Effusion,Otitis Media, Secretory,Otitis Media, Serous,Ear Effusion, Middle,Ear Effusions, Middle,Effusion, Middle Ear,Effusions, Middle Ear,Middle Ear Effusions,Secretory Otitis Media,Serous Otitis Media
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002972 Cleft Palate Congenital fissure of the soft and/or hard palate, due to faulty fusion. Cleft Palate, Isolated,Cleft Palates,Palate, Cleft,Palates, Cleft
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R F Yellon, and G Leonard, and P T Marucha, and R Craven, and R J Carpenter, and W B Lehmann, and J A Burleson, and D L Kreutzer
June 1972, The Annals of otology, rhinology, and laryngology,
R F Yellon, and G Leonard, and P T Marucha, and R Craven, and R J Carpenter, and W B Lehmann, and J A Burleson, and D L Kreutzer
August 1995, Archives of otolaryngology--head & neck surgery,
R F Yellon, and G Leonard, and P T Marucha, and R Craven, and R J Carpenter, and W B Lehmann, and J A Burleson, and D L Kreutzer
January 2008, International journal of pediatric otorhinolaryngology,
R F Yellon, and G Leonard, and P T Marucha, and R Craven, and R J Carpenter, and W B Lehmann, and J A Burleson, and D L Kreutzer
January 1985, Auris, nasus, larynx,
R F Yellon, and G Leonard, and P T Marucha, and R Craven, and R J Carpenter, and W B Lehmann, and J A Burleson, and D L Kreutzer
January 1976, The Annals of otology, rhinology, and laryngology,
R F Yellon, and G Leonard, and P T Marucha, and R Craven, and R J Carpenter, and W B Lehmann, and J A Burleson, and D L Kreutzer
January 1976, The Annals of otology, rhinology, and laryngology,
R F Yellon, and G Leonard, and P T Marucha, and R Craven, and R J Carpenter, and W B Lehmann, and J A Burleson, and D L Kreutzer
May 1976, Archives of otolaryngology (Chicago, Ill. : 1960),
R F Yellon, and G Leonard, and P T Marucha, and R Craven, and R J Carpenter, and W B Lehmann, and J A Burleson, and D L Kreutzer
March 1978, The Laryngoscope,
R F Yellon, and G Leonard, and P T Marucha, and R Craven, and R J Carpenter, and W B Lehmann, and J A Burleson, and D L Kreutzer
April 1987, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery,
R F Yellon, and G Leonard, and P T Marucha, and R Craven, and R J Carpenter, and W B Lehmann, and J A Burleson, and D L Kreutzer
January 1976, The Annals of otology, rhinology, and laryngology,
Copied contents to your clipboard!